Michael Bronfein is a serial entrepreneur and investor with a specific focus on innovation and competitive advantage in healthcare services, healthcare technologies, software, and distribution. A visionary known for assembling excellent management teams resulting in market leading high growth organizations with clear brand propositions and strong financial returns, Michael has founded or co-founded and rapidly grown, as either CEO, Director, or investor, a number of market leading innovative companies in healthcare services and technology.
Consistent with his focus on innovation in healthcare, Michael is leading a team of scientists, pharmacologists, physicians, horticulturists, and agronomists in developing new medicines based on the Cannabis plant. The Company Curio aspires to be a market leader in creating medicinal products and herbal supplements in traditional dosage forms such as pills, capsules, ointments, liquids and transdermal patches. The Company has raised $30 million in equity capital, purchased a 55,000 square foot manufacturing plant, and is awaiting the award of licenses to operate in Maryland.
Most recently Michael served as Co-Founder, Chairman and CEO of Remedi SeniorCare (www.remedirx.com), which has grown from a start up to the 5th largest Long Term Care Pharmacy in the US serving approximately 45,000 nursing home and assisted living residents in 12 states. Michael initiated this investment while leading healthcare investing for Sterling Partners and migrated to an operating role in 2010. Remedi’s rapid growth and success has been driven by its proprietary disruptive technology Paxit, which is the world’s first and only fully automated high output robotic medication packaging system. The Paxit system is revolutionizing the long-term care pharmacy industry by reducing drug costs 15% and increasing nursing productivity 30% while achieving a 100% accuracy rate in dispensing.
Prior to joining Remedi, Michael was Co-founder and Senior Managing Director of Sterling Partners, a growth capital private equity fund with a focus on education, healthcare services and technologies and business Services. Michael and his partners grew the company from a start up to over $4 Billion in assets under management. At Sterling, Michael led investments in VISICU and VOCUS both of which resulted in IPOs for the companies.
Prior to founding Sterling Partners, Michael was Co-founder, Chairman & CEO of NeighborCare. Started as a traditional drugstore in Baltimore, NeighborCare became the second largest Long Term and Managed Care Pharmacy in the US servicing 250,000 long term care residents and 300,000 managed care patients daily. Michael received the Ernst & Young Entrepreneur of the Year award in 1994 for the business model and concept for NeighborCare.
Prior to founding NeighborCare Michael led commercial finance lending for Signet Bank and held various management positions in the retail food industry.
Michael serves as the inaugural Chairman of the Senior Care Pharmacy Coalition a Washington, DC based advocacy group whose sole focus is the financial viability and health of the long term care pharmacy industry. In addition to his focus on building great companies, Michael is actively involved in the community. He currently serves on the advisory board of the Bloomberg School of Public Health at Johns Hopkins University and the Harvard Medical School. He is also the past Chairman of the Board of the Baltimore Symphony Orchestra.
Michael is a graduate of the University of Baltimore with a BS in Accounting and is a Certified Public Accountant. He resides in Owings Mills, Maryland and Jupiter Florida with his wife of 40 years Jessica and is the proud father of three adult children and one granddaughter.
Menu
Menu
